117 related articles for article (PubMed ID: 11557364)
21. [Transforming growth factor-β1 small interfering RNA regulates platelet-derived growth factor and phosphorylated extracellular regulated protein kinase in rats with hepatic fibrosis: an experimental study].
Zhou XF; Jiang YJ; Zhang Y; Sun H; Liu Q; Shi XF
Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):701-705. PubMed ID: 29108193
[No Abstract] [Full Text] [Related]
22. Effects of transforming growth factor-beta and platelet-derived growth factor on oligodendrocyte precursors: insights gained from a neuronal cell line.
Asakura K; Hunter SF; Rodriguez M
J Neurochem; 1997 Jun; 68(6):2281-90. PubMed ID: 9166720
[TBL] [Abstract][Full Text] [Related]
23. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.
De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P
J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma differentially regulates TGF-beta1 and TGF-beta2 expression in human retinal pigment epithelial cells through JAK-STAT pathway.
Nagineni CN; Cherukuri KS; Kutty V; Detrick B; Hooks JJ
J Cell Physiol; 2007 Jan; 210(1):192-200. PubMed ID: 17013806
[TBL] [Abstract][Full Text] [Related]
25. Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland.
Yoshino K; Garg R; Monroy D; Ji Z; Pflugfelder SC
Curr Eye Res; 1996 Jun; 15(6):615-24. PubMed ID: 8670764
[TBL] [Abstract][Full Text] [Related]
26. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
Kassem M; Kveiborg M; Eriksen EF
Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries.
Ward MR; Sasahara T; Agrotis A; Dilley RJ; Jennings GL; Bobik A
Atherosclerosis; 1998 Apr; 137(2):267-75. PubMed ID: 9622270
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of platelet-derived growth factor BB and transforming growth factor in patients with failed hip prostheses.
Cenni E; Savarino L; Antonioli D; Pellacani A; Giunti A; Baldini N
Acta Orthop; 2005 Feb; 76(1):61-6. PubMed ID: 15788309
[TBL] [Abstract][Full Text] [Related]
30. Osteoclasts and transforming growth factor-beta: estrogen-mediated isoform-specific regulation of production.
Robinson JA; Riggs BL; Spelsberg TC; Oursler MJ
Endocrinology; 1996 Feb; 137(2):615-21. PubMed ID: 8593810
[TBL] [Abstract][Full Text] [Related]
31. Differential and synergistic effects of platelet-derived growth factor-BB and transforming growth factor-beta1 on activated pancreatic stellate cells.
Kordes C; Brookmann S; Häussinger D; Klonowski-Stumpe H
Pancreas; 2005 Aug; 31(2):156-67. PubMed ID: 16025003
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
33. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone.
Horner A; Kemp P; Summers C; Bord S; Bishop NJ; Kelsall AW; Coleman N; Compston JE
Bone; 1998 Aug; 23(2):95-102. PubMed ID: 9701467
[TBL] [Abstract][Full Text] [Related]
34. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3.
Toom A; Arend A; Gunnarsson D; Ulfsparre R; Suutre S; Haviko T; Selstam G
Calcif Tissue Int; 2007 Apr; 80(4):259-67. PubMed ID: 17401695
[TBL] [Abstract][Full Text] [Related]
35. Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow.
Yoon SY; Tefferi A; Li CY
Acta Haematol; 2000; 104(4):151-7. PubMed ID: 11279303
[TBL] [Abstract][Full Text] [Related]
36. Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms.
Makhijani NS; Bischoff DS; Yamaguchi DT
J Cell Physiol; 2005 Jan; 202(1):304-13. PubMed ID: 15389595
[TBL] [Abstract][Full Text] [Related]
37. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy.
Vedi S; Purdie DW; Ballard P; Bord S; Cooper AC; Compston JE
Osteoporos Int; 1999; 10(1):52-8. PubMed ID: 10501780
[TBL] [Abstract][Full Text] [Related]
38. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism of teratogenic effects induced by the fungicide triadimefon: study of the expression of TGF-beta mRNA and TGF-beta and CRABPI proteins during rat in vitro development.
Di Renzo F; Corsini E; Broccia ML; Marinovich M; Galli CL; Giavini E; Menegola E
Toxicol Appl Pharmacol; 2009 Jan; 234(1):107-16. PubMed ID: 18976680
[TBL] [Abstract][Full Text] [Related]
40. Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.
Finkelman RD; Bell NH; Strong DD; Demers LM; Baylink DJ
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12190-3. PubMed ID: 1465458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
